Dela Cruz, Liza V.

HRN: 19-72-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/22/2026
06/28/2026
IV
1.5G
Q6
Breastmass, Right
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines